Re-Vana Therapeutics raised €11M in a Series A round in Nov 2022. The company is based in Belfast, UK. Investors in the round: Co-Fund NI, ExSight Ventures, QUBIS and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
